The Food and Drug Administration (FDA) has approved the immunotherapy drug atezolizumab in combination with chemotherapy for ...

Circulating tumor DNA (ctDNA)—genetic material shed from tumors into the bloodstream—may help risk-stratify patients with Stage 3 colon cancer by tailoring chemotherapy options after surgery based on ...

The Food and Drug Administration (FDA) approved Tecentriq (atezolizumab) in combination with chemotherapy on Oct. 8 as an ...

I was hospitalized for the first time in my life for colon cancer surgery—it was okay to say, 'I'm scared'In my previous ...

(9926.HK) ("Akeso" or the "Company") announced that the first patient has been dosed in a Phase III clinical study ...

Colon cancer is the third most prevalent form of cancer in the U.S., and while screening has helped detect and prevent colon cancer from spreading, major advancements in treating colon cancer have ...

Tecentriq is now the first immunotherapy indicated for dMMR colon cancer treatment specifically, which is often linked to a higher risk of progression after surgery.

A pattern-based p53 immunohistochemistry test identified patients with colorectal liver metastases at nearly four times the ...

These Detroit, MI hospitals are evaluated on how well they perform Colon Cancer Surgery using data such as nurse staffing, patient volume, patient survival and more. Hospitals are rated as high ...